(Q24563046)

English

Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study

scientific article

In more languages

Statements

scholarly article

0 references

Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study (English)

0 references

obstetrics and gynaecology

0 references

reproductive medicine

0 references

0 references

ulipristal acetate

1 reference

based on heuristic

inferred from title

uterine fibroid

1 reference

based on heuristic

inferred from title

Tonja R. Nansel

object named as

Tonja Nansel

3

0 references

Lynnette K Nieman

1

object named as

Lynnette K Nieman

0 references

author name string

Wendy Blocker

2

0 references

Sheila Mahoney

4

0 references

James Reynolds

5

0 references

Diana Blithe

6

0 references

Robert Wesley

7

0 references

Alicia Armstrong

8

0 references

language of work or name

0 references

publication date

February 2011

0 references

Fertility and Sterility

0 references

95

0 references

767-72.e1-2

0 references

2

0 references

High aromatase expression in uterine leiomyoma tissues of African-American women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

24 March 2017

CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

24 March 2017

In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

24 March 2017

Progesterone antagonists and progesterone receptor modulators: an overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

24 March 2017

Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

Molecular genetics and racial disparities of uterine leiomyomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

The spectrum of endometrial pathology induced by progesterone receptor modulators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

Uterine fibroids: a review of health-related quality of life assessment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

The economic impact of uterine fibroids in the United States: a summary of published estimates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

27 September 2017

Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

30 May 2018

Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

30 May 2018

Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

30 May 2018

Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

28 November 2018

Impaired work performance among women with symptomatic uterine fibroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

28 November 2018

Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

28 November 2018

Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

28 November 2018

Annual costs associated with diagnosis of uterine leiomyomata.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

28 November 2018

Mid- and long-term quality-of-life assessment in patients undergoing uterine fibroid embolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

28 November 2018

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180231

28 November 2018

A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone

1 reference

https://pubmed.ncbi.nlm.nih.gov/21055739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21055739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of gonadotrophin-releasing hormone agonist on uterine fibroids and bone density

1 reference

https://pubmed.ncbi.nlm.nih.gov/21055739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine leiomyomata. Number 192--May 1994. ACOG technical bulletin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21055739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21055739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21055739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21055739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.FERTNSTERT.2010.09.059

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24563046&oldid=2043288665"